Insights

Filters   Sort By Newest  
Newest Oldest Title
Updating results

Showing results 1 - 12 of 12 Results per page:

No results found.

  • Advertising, Marketing & Regulatory
  • Artificial Intelligence
  • Automotive
  • Cannabis
  • Chemical
  • Chemical AI
  • Cleantech
  • Copyright & Digital Media
  • Electrical & Computer Technology
  • Financial Technology
  • Industrial Designs
  • IP Management & Strategic Counselling
  • Licensing & Transactions
  • Life Sciences
  • Litigation & Dispute Resolution
  • Mechanical & Industrial Processes
  • Medical Technology
  • Nanotechnology
  • Oil & Gas
  • Patents
  • Plant Breeders’ Rights
  • Privacy & Data Protection
  • Psychedelics
  • Quantum Technologies
  • Trademarks
  • Nicholas Aitken
  • Arvin Angue
  • Adam Aucoin
  • William Audet
  • Ryan Baker
  • Christie J. C. Bates
  • Stephen Beney
  • Brett Benham
  • Daniel Bereskin
  • Janice M. Bereskin
  • Shaivi Bhatt
  • Adam Bierylo
  • Paul David Blizzard
  • Adam Bobker
  • Jennifer Boothby
  • Chantalle Briggs
  • Jonathan G. Burkinshaw
  • Don Cameron
  • Isi Caulder
  • Brigitte Chan
  • Wynnie Chan
  • Mina Chana
  • Herman Cheung
  • Iris Cheung
  • Kyle Classen
  • Toba Cooper
  • Noel Courage
  • Carmela De Luca
  • Ryan De Vries
  • Reshika Dhir
  • Meghan Dillon
  • Terry Edwards
  • Prudence Ariella Etkin
  • Michael Fenwick
  • Patricia Folkins
  • Cameron Gale
  • Matthew John Graff
  • Louis-Pierre Gravelle
  • Micheline Gravelle
  • Gail Hung
  • Nicole Hunter
  • Jason Hynes
  • Alissa Hyppolite
  • Nyrie Israelian
  • Susan J. Keri
  • Denis V. Keseris
  • Ellen Kiernan
  • Simone Knott
  • Ray Kovarik
  • Victor Krichker
  • Dominique Lambert
  • François Larose
  • Julia London
  • Maddie Lynch
  • Joanna Ma
  • R. Scott MacKendrick
  • Don MacOdrum
  • Jennifer Manley
  • Sandra Marone
  • Andrew McIntosh
  • Melissa J. McKeon
  • Ian McMillan
  • Philip C. Mendes da Costa
  • Hailey Min
  • David Morrison
  • Luba Naiberger
  • Paige Newman
  • Andrea Ngo
  • Tony Orsi
  • Ainslie Parsons
  • Chelsea Pham
  • Justin Philpott
  • Scott Pundsack
  • James Raakman
  • Mohamed Rahal
  • Bhupinder Randhawa
  • Sunil Rao
  • Kimberly Ren
  • Coralee Ridder
  • Mark L. Robbins
  • Jane Sargeant
  • Timothy Sinnott
  • Parnian Soltanipanah
  • Josh Spicer
  • David St-Martin
  • Kate Stewart-Tiralongo
  • Robert Storey
  • Jessica R. Sudbury
  • Melanie Szweras
  • Benjamin Todd
  • Andrea Uetrecht
  • Charles Wang
  • Maria Wei
  • Tamara Céline Winegust
  • Shuo Xing
  • Leanne Young
  • Jennie Yum
  • Previous 30 days
  • Previous 90 days
  • Previous year
  • From to

Explore our Insights

November 10, 2022
PMPRB Regulations Saga Coming to an End? New Draft Guidelines Issued
By Nyrie Israelian, Parnian Soltanipanah, Melanie Szweras, Noel Courage 
›
June 2, 2022
Federal Court sets aside Minister of Health’s approval of RUZURGI for the second time over data protection dispute
›
April 22, 2022
Canada Drops its Most Controversial Patented Drug Pricing Amendments
By Nyrie Israelian and Noel Courage
›
April 1, 2022
Supreme Court of Canada Takes a Pass on Patented Drug Price Dispute
By: Nyrie Israelian and Noel Courage
›
March 8, 2022
Federal Court Interprets Patent Act Amendments to Prior User Rights Provisions
By Melanie Szweras and Nyrie Israelian
›
March 1, 2022
2021 Year in Review: IP Litigation
By Adam Bobker, Andrew McIntosh, Martin Brandsma and Nyrie Israelian
›
February 28, 2022
Proposed Canadian Drug Pricing Rules Delayed by Feds and Battered by Courts 
By Noel Courage and Nyrie Israelian
›
February 7, 2022
Soundly Predicted, But Not Obvious: Validity of MS Drug Patent Upheld on Appeal
By Martin Brandsma and Nyrie Israelian
›
November 19, 2021
Federal Court finds Minister of Health’s refusal of BELSOMRA CSP unreasonable, remits for redetermination
By Melanie Szweras and Nyrie Israelian
›
August 5, 2021
Canadian Drug Price Review Board Reined In
By Noel Courage and Nyrie Israelian
›
September 30, 2019
Canadian Drug Price Review of Generic Companies Holding Patents
By Noel Courage and Nyrie Israelian
›
August 7, 2019
While Americans Laud “Low” Canadian Drug Prices, Canadian Innovative Pharma Waits to see if the Pricing Axe Will Fall on “Excessive” Canadian Drug Prices
By Noel Courage and Nyrie Israelian
›
Loading...

Showing results 1 - 12 of 12 Results per page:

No results found.

Subscribe to our newsletter

You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

This site is registered on wpml.org as a development site.